Actemra 162 (Tocilizumab Vials) 162mg/0.9ml

Actemra 162mg/0.9ml (tocilizumab) is an injectable medication used for immune system regulation. This single-use vial contains 162mg of tocilizumab in 0.9ml solution. Suitable for subcutaneous injection, it supports treatment of inflammatory conditions when prescribed.

Strength

162mg/0.9ml

Manufacturer / TM Owner

Hoffmann La Roche Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Actemra 162mg/0.9ml is used to help manage symptoms of moderate to severe rheumatoid arthritis in adults. It works by targeting specific pathways in the immune system to reduce inflammation. The medication may also be prescribed for giant cell arteritis or juvenile idiopathic arthritis in certain cases.

Side Effects

Users may notice reduced joint pain and swelling after starting Actemra 162mg/0.9ml. Some individuals report improved mobility and daily function as inflammation decreases. Effects vary by person and condition being treated.

Precautions & Warnings

Store Actemra 162mg/0.9ml vials in the refrigerator until use. Protect from light and avoid freezing. Keep out of reach of children. Discard any unused portion after injection. Always follow healthcare provider instructions for proper handling and disposal.

Avoid Interactions

Actemra 162mg/0.9ml may interact with other medications that affect the immune system. Caution is advised when combining with live vaccines or strong CYP3A4 inhibitors. Alcohol use should be discussed with a healthcare provider before starting treatment.

Frequently Asked Questions

Actemra 162mg/0.9ml is used to treat inflammatory conditions like rheumatoid arthritis when prescribed by a doctor.

It is given as a subcutaneous injection, typically into the thigh or abdomen, following healthcare provider instructions.

Actemra 162mg/0.9ml requires a prescription and should only be obtained from licensed pharmacies.

Common effects may include injection site reactions or mild upper respiratory symptoms.

Pregnancy use should be discussed with a healthcare provider to weigh potential risks and benefits.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.